Bailard, Inc. Decibel Therapeutics, Inc. Transaction History

Bailard, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	BUY	$2.41 - $4.81 $25,546 - $50,985	10,600 New	10,600 $40,000
Q2 2022 Jul 27, 2022	SELL	$1.85 - $4.21 $36,445 - $82,937	-19,700 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$2.83 - $5.03 $55,751 - $99,091	19,700 New	19,700 $60,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.